163 related articles for article (PubMed ID: 38223538)
1. Oral TNF-α siRNA delivery via milk-derived exosomes for effective treatment of inflammatory bowel disease.
Han G; Kim H; Jang H; Kim ES; Kim SH; Yang Y
Bioact Mater; 2024 Apr; 34():138-149. PubMed ID: 38223538
[TBL] [Abstract][Full Text] [Related]
2. Construction of cryomicroneedles loaded with milk-derived exosomes encapsulated TNF-α siRNA and efficacy of percutaneous acupoint administration in rheumatoid arthritis.
Wen W; Yang J; Liang X; Li Y; Zhang W; Sun X; Wang R
Int J Pharm; 2024 May; 657():124159. PubMed ID: 38701907
[TBL] [Abstract][Full Text] [Related]
3. Gemini lipid nanoparticle (GLNP)-mediated oral delivery of TNF-α siRNA mitigates gut inflammation
Verma P; Arora A; Rana K; Mehta D; Kar R; Verma V; Srikanth CV; Patil VS; Bajaj A
Nanoscale; 2022 Oct; 14(39):14717-14731. PubMed ID: 36169577
[TBL] [Abstract][Full Text] [Related]
4. Bovine colostrum derived-exosomes prevent dextran sulfate sodium-induced intestinal colitis
Han G; Cho H; Kim H; Jang Y; Jang H; Kim DE; Kim ES; Kim EH; Hwang KY; Kim K; Yang Y; Kim SH
Biomater Sci; 2022 Apr; 10(8):2076-2087. PubMed ID: 35315847
[TBL] [Abstract][Full Text] [Related]
5. Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease.
Shrestha N; Xu Y; Prévost JRC; McCartney F; Brayden D; Frédérick R; Beloqui A; Préat V
Acta Biomater; 2022 Mar; 140():561-572. PubMed ID: 34923097
[TBL] [Abstract][Full Text] [Related]
6. A novel therapeutic approach for inflammatory bowel disease by exosomes derived from human umbilical cord mesenchymal stem cells to repair intestinal barrier via TSG-6.
Yang S; Liang X; Song J; Li C; Liu A; Luo Y; Ma H; Tan Y; Zhang X
Stem Cell Res Ther; 2021 May; 12(1):315. PubMed ID: 34051868
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the Th17/Treg balance by human umbilical cord mesenchymal stem cell-derived exosomes protects against acute experimental colitis.
Heidari N; Abbasi-Kenarsari H; Namaki S; Baghaei K; Zali MR; Mirsanei Z; Hashemi SM
Exp Cell Res; 2022 Oct; 419(1):113296. PubMed ID: 35917844
[TBL] [Abstract][Full Text] [Related]
8. Gene silencing of TNF-alpha in a murine model of acute colitis using a modified cyclodextrin delivery system.
McCarthy J; O'Neill MJ; Bourre L; Walsh D; Quinlan A; Hurley G; Ogier J; Shanahan F; Melgar S; Darcy R; O'Driscoll CM
J Control Release; 2013 May; 168(1):28-34. PubMed ID: 23500058
[TBL] [Abstract][Full Text] [Related]
9. Construction and Evaluation of Liraglutide Delivery System based on Milk Exosomes: A New Idea for Oral Peptide Delivery.
Shi Y; Guo S; Liang Y; Liu L; Wang A; Sun K; Li Y
Curr Pharm Biotechnol; 2022; 23(8):1072-1079. PubMed ID: 34414872
[TBL] [Abstract][Full Text] [Related]
10. Delivery of High Mobility Group Box-1 siRNA Using Brain-Targeting Exosomes for Ischemic Stroke Therapy.
Kim M; Kim G; Hwang DW; Lee M
J Biomed Nanotechnol; 2019 Dec; 15(12):2401-2412. PubMed ID: 31748020
[TBL] [Abstract][Full Text] [Related]
11. Dual TNF-α/Cyclin D1 Gene Silencing With an Oral Polymeric Microparticle System as a Novel Strategy for the Treatment of Inflammatory Bowel Disease.
Kriegel C; Amiji MM
Clin Transl Gastroenterol; 2011 Mar; 2(3):e2. PubMed ID: 23237848
[TBL] [Abstract][Full Text] [Related]
12. An orally administrated nucleotide-delivery vehicle targeting colonic macrophages for the treatment of inflammatory bowel disease.
Huang Z; Gan J; Jia L; Guo G; Wang C; Zang Y; Ding Z; Chen J; Zhang J; Dong L
Biomaterials; 2015 Apr; 48():26-36. PubMed ID: 25701029
[TBL] [Abstract][Full Text] [Related]
13. Oral TNF-α gene silencing using a polymeric microsphere-based delivery system for the treatment of inflammatory bowel disease.
Kriegel C; Amiji M
J Control Release; 2011 Feb; 150(1):77-86. PubMed ID: 20959130
[TBL] [Abstract][Full Text] [Related]
14. Ultrasound-Mediated Delivery of RNA to Colonic Mucosa of Live Mice.
Schoellhammer CM; Lauwers GY; Goettel JA; Oberli MA; Cleveland C; Park JY; Minahan D; Chen Y; Anderson DG; Jaklenec A; Snapper SB; Langer R; Traverso G
Gastroenterology; 2017 Apr; 152(5):1151-1160. PubMed ID: 28088460
[TBL] [Abstract][Full Text] [Related]
15. Oral delivery of anti-TNF antibody shielded by natural polyphenol-mediated supramolecular assembly for inflammatory bowel disease therapy.
Wang X; Yan J; Wang L; Pan D; Xu Y; Wang F; Sheng J; Li X; Yang M
Theranostics; 2020; 10(23):10808-10822. PubMed ID: 32929381
[No Abstract] [Full Text] [Related]
16. Spinal cord injury target-immunotherapy with TNF-α autoregulated and feedback-controlled human umbilical cord mesenchymal stem cell derived exosomes remodelled by CRISPR/Cas9 plasmid.
Wang B; Chang M; Zhang R; Wo J; Wu B; Zhang H; Zhou Z; Li Z; Zhang F; Zhong C; Tang S; Yang S; Sun G
Biomater Adv; 2022 Feb; 133():112624. PubMed ID: 35525736
[TBL] [Abstract][Full Text] [Related]
17. Milk exosomes - Natural nanoparticles for siRNA delivery.
Aqil F; Munagala R; Jeyabalan J; Agrawal AK; Kyakulaga AH; Wilcher SA; Gupta RC
Cancer Lett; 2019 May; 449():186-195. PubMed ID: 30771430
[TBL] [Abstract][Full Text] [Related]
18. Orally targeted galactosylated chitosan poly(lactic-co-glycolic acid) nanoparticles loaded with TNF-ɑ siRNA provide a novel strategy for the experimental treatment of ulcerative colitis.
Huang Y; Guo J; Gui S
Eur J Pharm Sci; 2018 Dec; 125():232-243. PubMed ID: 30315858
[TBL] [Abstract][Full Text] [Related]
19. The Anti-Inflammatory Effects of Adipose Tissue Mesenchymal Stem Cell Exosomes in a Mouse Model of Inflammatory Bowel Disease.
Lee JH; Lötvall J; Cho BS
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069197
[TBL] [Abstract][Full Text] [Related]
20. Cow and Human Milk-Derived Exosomes Ameliorate Colitis in DSS Murine Model.
Reif S; Elbaum-Shiff Y; Koroukhov N; Shilo I; Musseri M; Golan-Gerstl R
Nutrients; 2020 Aug; 12(9):. PubMed ID: 32858892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
